uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Cyclin D1 expression is associated with poor prognostic features in estrogen receptor positive breast cancer
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology.
Show others and affiliations
2009 (English)In: Breast Cancer Research and Treatment, ISSN 0167-6806, E-ISSN 1573-7217, Vol. 113, no 1, 75-82 p.Article in journal (Refereed) Published
Abstract [en]

Cyclins D1 and E play an important role in breast carcinogenesis. High cyclin E expression is common in hormone receptor negative and high grade aggressive breast cancer, whereas cyclin D1 in hormone receptor positive and low grade breast cancer. Experimental data has suggested that cyclin D1 and E mediate cell proliferation by different mechanisms in estrogen receptor (ER) positive and negative breast cancer. To test this hypotheses in large breast cancer material and to clarify the histopathological correlations of cyclin E and D1, especially the association with proliferation, we analyzed cyclin E and D1 immunohistochemical expression on breast tumour microarrays consisting of 1348 invasive breast cancers. High cyclin D1 expression was associated with high grade (P<0.0005), high cyclin A (P<0.0005) and Ki67 (P<0.0005) expression among ER positive but with low grade (P=0.05) and low Ki67 (P=0.01) expression among ER negative breast cancers. Cyclin E and D1 expression correlated positively in ER positive (P<0.0005) but had a negative correlation in ER negative tumours (P=0.004). Cyclin E associated with high grade among all tumours (P<0.0005). In conclusion, the findings of this study show that cyclin D1 has separate roles, and proliferation is driven by different mechanisms in ER positive and negative breast cancers.

Place, publisher, year, edition, pages
2009. Vol. 113, no 1, 75-82 p.
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-105533DOI: 10.1007/s10549-008-9908-5ISI: 000261951100009PubMedID: 18240019OAI: oai:DiVA.org:uu-105533DiVA: diva2:221445
Available from: 2009-06-04 Created: 2009-06-04 Last updated: 2012-03-15Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed
By organisation
Department of Immunology, Genetics and PathologyOncology
In the same journal
Breast Cancer Research and Treatment
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 602 hits
ReferencesLink to record
Permanent link

Direct link